PUBBLICAZIONI GISCAD

pagina 6

· 

Randomized trial of intraportal and/or systemic adjuvant chemotherapy in patients with colon carcinoma

J Natl Cancer Inst 2004; May 19 96(10): 750-8

Labianca R, Fossati R, Zaniboni A, Torri V, Marsoni S, Nitti D, Boffi L, Scatizzi M, Tardio B, Mastrodonato N, Banducci S, Consani G, Pancera G: ACOI/GIVIO/GISCAD

· 

High curative resection rate with weekly cisplatin, 5- Fluorouracil, epidoxorubicin, 6S-leucovorin, glutathione, and filgrastim in patients with locally advanced, unresectable gastric cancer: a report from GISCAD

 Br J Cancer 2004; Apr 19 90(8): 1521-5

Cascina S, Scartozzi M, Labianca R, Catalano V, Silva RR, Barni S, Zaniboni A, D'angelo A, Salvagni S, Martignoni G, Beretta GD, Graziano F, Berardi R, Franciosi V: the Italian Group for the Study of Digestive Tract Cancer (GISCAD).

· 

A phase II study of weekly cisplatin, 6 Sstereoisomer leucovorin and fluorouracil as first-line chemotherapy for elderly patients with advanced gastric cancer

· 

Weekly gemcitabine and cisplatin chemotherapy: a well-tolerated but ineffective chemotherapeutic regimen in advanced pancreatic cancer patients. A report from the Italian Group for the Study of Digestive Tract Cancer (GISCAD)

Br J Cancer 2003; Oct 20 89(8): 1428-32

Graziano F, Santini D, Testa E,  Catalano V, Beretta GD, Mosconi S, Tonini G, Lai, Labianca R, Cascinu S.

Ann Oncol 2003; Feb 14(2): 205-8

Cascinu S, Labianca R, Catalano V, Barni S, Ferraù F, Beretta GD, Frontini L, Foa P, Pancera G, Priolo D, Graziano F, Mare M, Catalano G.

Br J Cancer 2003; Jan 21 86(2): 213-7

· 

Infusional 5-fluorouracil, cisplatin and mitomycin C in advanced gastric cancer: a low cost effective regimen

Cascinu S, Baldelli AM, Catalano V, Giordani P, Beretta GD, Silva RR, Gasparini G, Mari D, Maisano R, Salvagni S, Barni S, Labianca R, Frontini L, Curti C, Catalano G.

· 

Raltitrexed plus oxaliplatin (TOMOX) as first-line chemotherapy for metastatic colorectal cancer. A phase II study of the Italian Group for the Study of Digestive Tract Cancer (GISCAD)

Ann Oncol 2002; May 13(5): 716-20

Cascinu S, Graziano F, Ferrù F, Catalano V, Massacesi C, Santini D, Silva RR, Barni S,  Zaniboni  A, Battelli N, Siena S, Giordani P,  Mari D, Baldelli AM, Antognoli S, Maisano R, Priolo D, Pessi MA, Tonini G, Rota S, Labianca R.

FONDAZIONE
GISCAD

GRUPPO ITALIANO PER LO STUDIO DEI 

CARCINOMI DELL'APPARATO DIGERENTE

SEDE

Via Gattinoni, 4

20043 Vanzago (MI)

CONTATTI

Tel. 02 84968409

ufficio.operativo@giscad.it

© 2018 Fondazione GISCAD - P.IVA 05396970963